Multiplex single‐cell profiling of putative cancer stem cell markers ALDH1, SOX9, SOX2, CD44, CD133 and CD15 in endometrial cancer

The presence of cancer stem cells is linked to aggressive disease and higher risk of recurrence, and multiple markers have been proposed to detect cancer stem cells. However, a detailed evaluation of the expression patterns and the prognostic value of markers relevant for endometrial cancer is lacki...

Full description

Bibliographic Details
Published in:	Molecular Oncology
Main Authors:	Hilde E. Lien, Marta E. Hjelmeland, Hege F. Berg, Rose M. Gold, Kathrine Woie, Lars A. Akslen, Ingfrid S. Haldorsen, Camilla Krakstad
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Subjects:	cancer stem cells endometrial cancer imaging mass cytometry patient‐derived organoids single cell tumor heterogeneity
Online Access:	https://doi.org/10.1002/1878-0261.13815

Similar Items

Expression of CD133-stem cell marker in colorectal cancer
by: Michał Zwoliński, et al.
Published: (2025-09-01)

Single-cell sequencing reveals CD133+CD44−-originating evolution and novel stemness related variants in human colorectal cancer
by: Xiaoyan Zhang, et al.
Published: (2022-08-01)

DNA alterations in Cd133+ and Cd133- tumour cells enriched from intra-operative human colon tumour biopsies
by: Diana Cervantes-Madrid, et al.
Published: (2017-03-01)

In vitro characterization of CD133lo cancer stem cells in Retinoblastoma Y79 cell line
by: Rohini M. Nair, et al.
Published: (2017-11-01)

Protocol for sorting cancer stem cells using a combination of anti-CD133 antibody and lectin cyanovirin-N
by: Yuanyan Wei, et al.
Published: (2024-12-01)

Evaluation of stemness genes expression of OCT4, SOX2, Nanog, C-Myc and surface marker of CD133 on myeloma cells
by: Ramin Saadatian kharajo, et al.
Published: (2020-04-01)

Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker
by: Schneider Meike, et al.
Published: (2012-03-01)

FEATURES OF EXPRESSION OF CD133 AND CD44 MARKERS OF TUMOR STEM CELLS WITH METASTATIC AND NON-METASTATIC GASTRIC CANCER
by: A. B. Sagakyants, et al.
Published: (2021-03-01)

SOX17 expression in tumor‐penetrating vessels in relation to CD8+ T‐cell infiltration in cancer stroma niches
by: Hirotaka Yamamoto, et al.
Published: (2024-11-01)

Secreted factors from M1 macrophages drive prostate cancer stem cell plasticity by upregulating NANOG, SOX2, and CD44 through NFκB-signaling
by: Kirsi Kainulainen, et al.
Published: (2024-12-01)

PD-L1+ CD49f+ CD133+ Circulating tumor cells predict outcome of patients with vulvar or cervical cancer after radio- and chemoradiotherapy
by: Selina Gies, et al.
Published: (2025-03-01)

Unveiling the impact of CD133 on cell cycle regulation in radio- and chemo-resistance of cancer stem cells
by: Luyao Wu, et al.
Published: (2025-02-01)

Possible role of ALDH1 and CD44 in lip carcinogenesis
by: Rafael Carneiro ORTIZ, et al.
Published: (2023-12-01)

Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent diseaseResearch in context
by: Hilde E. Lien, et al.
Published: (2023-06-01)

Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells
by: Xiaolong Huang, et al.
Published: (2017-08-01)

Cobalt ferrite nanoparticle for the elimination of CD133+CD44+ and CD44+CD24−, in breast and skin cancer stem cells, using non-ionizing treatments
by: Bahareh Khalili Najafabad, et al.
Published: (2023-10-01)

Early stage evaluation of cancer stem cells using platinum nanoparticles/CD133 + enhanced nanobiocomposite
by: Solmaz Sadi, et al.
Published: (2023-05-01)

Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2
by: Yonghao Zhan, et al.
Published: (2020-02-01)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
by: Fritzenwanger M, et al.
Published: (2009-03-01)

MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway
by: Massimo Moro, et al.
Published: (2022-02-01)

Loss of vimentin expression in preoperative biopsies independently predicts poor prognosis, lymph node metastasis and recurrence in endometrial cancer
by: Marta E. Hjelmeland, et al.
Published: (2024-10-01)

Significance of CD133 positive cells in four novel HPV-16 positive cervical cancer-derived cell lines and biopsies of invasive cervical cancer
by: Shifa Javed, et al.
Published: (2018-04-01)

DNA mismatch repair and CD133-marked cancer stem cells in colorectal carcinoma
by: Phaik-Leng Cheah, et al.
Published: (2018-09-01)

The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers
by: Min Kyung-Jin, et al.
Published: (2012-10-01)

Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma
by: Mohammed Saeed Rozeik, et al.
Published: (2017-07-01)

Imperatorin Targets MCL-1 to Sensitize CD133+ Lung Cancer Cells to γδ-T Cell-Mediated Cytotoxicity
by: Changxuan You, et al.
Published: (2018-08-01)

Rhaponticin suppresses the stemness phenotype of gastric cancer stem-like cells CD133+/CD166 + by inhibiting programmed death-ligand 1
by: Yulong Li, et al.
Published: (2024-11-01)

Sox2 promotes tamoxifen resistance in breast cancer cells
by: Marco Piva, et al.
Published: (2013-10-01)

Chemo-Sensitization of CD133+ Cancer Stem Cell Enhances the Effect of Mesenchymal Stem Cell Expressing TRAIL in Non-Small Cell Lung Cancer Cell Lines
by: Kamal Shaik Fakiruddin, et al.
Published: (2021-10-01)

Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers
by: Tae-Min Kim, et al.
Published: (2019-02-01)

SOX2OT knockdown derived changes in mitotic regulatory gene network of cancer cells
by: Marie Saghaeian Jazi, et al.
Published: (2018-09-01)

Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease
by: Petr Pleskač, et al.
Published: (2024-03-01)

Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer
by: Courtney M Schaal, et al.
Published: (2018-10-01)

Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin
by: Wang Yin, et al.
Published: (2022-11-01)

Delivery Of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers For Prostate Cancer
by: Ma Q, et al.
Published: (2019-11-01)

CRISPR screen reveals SOX2 as a critical regulator of CD133 and cellular stress response in glioblastoma
by: Neil Savage, et al.
Published: (2025-10-01)

Clinicopathological correlation of cancer stem cell markers Oct-4 and CD133 expression as prognostic factor in malignant lesions of gallbladder: An immunohistochemical study
by: Naseem Fatima, et al.
Published: (2019-01-01)

Sox9: A potential regulator of cancer stem cells in osteosarcoma
by: Li Xiucheng, et al.
Published: (2024-07-01)

Polyoxometalate inhibition of SOX2-mediated tamoxifen resistance in breast cancer
by: Iskander Aurrekoetxea-Rodriguez, et al.
Published: (2024-09-01)

Impact of SOX2 function and regulation on therapy resistance in bladder cancer
by: Guodong Chen, et al.
Published: (2022-11-01)